CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
Analgesia Nociception Indexdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02364856
NCT02364856N/ACompleted

Assessment of Pain Through Parasympathetic Tone Analysis : Applicability in Children With Cerebral Palsy.

University Hospital, Lille·observational·Posted Feb 18, 2015·Updated Apr 17, 2026

In Brief

An observational study evaluating Analgesia Nociception Index for Cerebral Palsy and 2 related conditions. Completed, enrolled 17 participants across 3 sites.

Detailed Summary

This study evaluates Analgesia Nociception Index (Heart Rate Variability based index) and its variations after painful stimulations in children with cerebral palsy : acute procedural pain (botulinum toxin injections), and recurrent pain (physiotherapy).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 18, 2015
Enrollment StartApr 24, 2015
Primary CompletionApr 12, 2018
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 11.4 years ago

Interventions

Analgesia Nociception Indexdevice

The Analgesia Nociception Index (ANI, MDoloris Medical Systems, Lille, France), based on Heart Rate Variability analysis, measures continuously and non-invasively the influence of Respiratory Sinus Arrhythmia on the heart rate. This 0-100 index indicates the proportion of paraS over sympathetic activity. In adults during surgery under general anesthesia, ANI decreases after painful stimulation and has been related to the balance between analgesia and nociception. ANI is calculated from heart rate recording.